
We're thrilled to launch OverT Bio! Debuting with $16M of initial financing, we will develop safe and effective #celltherapies for solid tumor cancers. endpts.com/overt-bio-debu…
Mat Legut, PhD
149 posts

@MatLegut
Unconventional T cell biologist and genome engineer. Previously @cardiffuni @nyuniversity @nygenome 🏳️🌈

We're thrilled to launch OverT Bio! Debuting with $16M of initial financing, we will develop safe and effective #celltherapies for solid tumor cancers. endpts.com/overt-bio-debu…


Our team in #Barcelona is expanding & we're #hiring 2 talented scientists to fill these exciting new positions: a Lead Scientist & a Research Associate. Do u want to make a real difference in the future of applied high-throughput genetics and therapeutics? #PhdChat #ScienceJobs

We're thrilled to launch OverT Bio! Debuting with $16M of initial financing, we will develop safe and effective #celltherapies for solid tumor cancers. endpts.com/overt-bio-debu…

We're thrilled to launch OverT Bio! Debuting with $16M of initial financing, we will develop safe and effective #celltherapies for solid tumor cancers. endpts.com/overt-bio-debu…



We're thrilled to launch OverT Bio! Debuting with $16M of initial financing, we will develop safe and effective #celltherapies for solid tumor cancers. endpts.com/overt-bio-debu…







Genetics Support w/ @nevillesanjana! youtu.be/C3T_IaIGQxo

NEW content online! Multiomics-guided cellular immunotherapies dlvr.it/SmTtT9


.@nevillesanjana and colleagues from NYU and @nygenome developed a genetic screening platform to identify genes that transform immune cells into more aggressive cancer fighters. Their promising study was published in @Nature. Vote for it in #statmadness: statnews.com/feature/stat-m…


